{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:23:20Z","timestamp":1781079800850,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the <jats:italic>TGF\u03b2R2<\/jats:italic> gene have been associated with a life threatening risk of aortic dissection but no arrhythmic death has been previously reported. Two young females carrying a <jats:italic>TGF\u03b2R2<\/jats:italic> mutation, initially diagnosed as Marfan syndrome or Loeys Dietz syndrome, presented sudden death with autopsy ruling out dissection. The ECGs of the 2 Sudden Cardiac Deaths revealed profound ventricular repolarization abnormalities with a sinusoidal T-U morphology associated with normal left ventricular ejection fraction. These data strongly suggest sudden cardiac arrhythmic deaths and prompted us to systematically study the repolarization pattern in the patients with <jats:italic>TGF\u03b2R2<\/jats:italic> mutations. ECG findings from 58 mutation carriers patients (<jats:italic>TGF\u03b2R2<\/jats:italic> group) were compared with those of 46 non-affected first degree relatives (control group). <jats:italic>TGF\u03b2R2<\/jats:italic> mutation was associated with ventricular repolarization abnormalities in 47% of patients (p\u2009&lt;\u20090.001 vs. controls), including a 19.6\u2009ms (95%CI 8.7; 30.5) QTc interval prolongation compared to the non-affected first degree relatives (p\u2009&lt;\u20090.001), higher prevalence of abnormal U waves (16% vs. 2%), and sinusoidal T-U morphology (10% vs. 0%). <jats:italic>TGF\u03b2R2<\/jats:italic> mutations can be associated with abnormal ventricular repolarization pattern, longer QT interval than non-carrier relatives and an increased risk for sudden death.<\/jats:p>","DOI":"10.1038\/s41598-018-31298-5","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:13:08Z","timestamp":1535022788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High prevalence of ventricular repolarization abnormalities in people carrying TGF\u03b2R2 mutations"],"prefix":"10.1038","volume":"8","author":[{"given":"F.","family":"Extramiana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Milleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-0546","authenticated-orcid":false,"given":"S.","family":"Elbitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Uccellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Langeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spentchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Arnoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Denjoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bouleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fressart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Iserin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maison-Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abifadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-4528","authenticated-orcid":false,"given":"A.","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"31298_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ng1194-264","volume":"8","author":"G Collod","year":"1994","unstructured":"Collod, G. et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet. 8, 264\u2013268 (1994).","journal-title":"Nat Genet."},{"key":"31298_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ng1392","volume":"36","author":"T Mizuguchi","year":"2004","unstructured":"Mizuguchi, T. et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 36, 855\u2013860 (2004).","journal-title":"Nat Genet."},{"key":"31298_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvq230","volume":"88","author":"S Inamoto","year":"2010","unstructured":"Inamoto, S. et al. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovasc Res. 88, 520\u2013529 (2010).","journal-title":"Cardiovasc Res."},{"key":"31298_CR4","doi-asserted-by":"publisher","first-page":"27581","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys, B. L. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGF\u03b2R2. Nat Genet. 37, 27581 (2005).","journal-title":"Nat Genet."},{"key":"31298_CR5","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","volume":"120","author":"D Attias","year":"2009","unstructured":"Attias, D. et al. Comparison of clinical presentations and outcomes between patients with TGF\u03b2R2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 120, 2541\u20132549 (2009).","journal-title":"Circulation."},{"issue":"195","key":"31298_CR6","doi-asserted-by":"publisher","first-page":"195ra94","DOI":"10.1126\/scitranslmed.3006448","volume":"5","author":"PA Frischmeyer-Guerrerio","year":"2013","unstructured":"Frischmeyer-Guerrerio, P. A. et al. TGF\u03b2 receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med. 5(195), 195ra94 (2013).","journal-title":"Sci Transl Med."},{"key":"31298_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1161\/CIRCGENETICS.116.001485","volume":"9","author":"G Jondeau","year":"2016","unstructured":"Jondeau, G. et al. Montalcino Aortic Consortium. International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet. 9, 548\u2013558 (2016).","journal-title":"Circ Cardiovasc Genet."},{"key":"31298_CR8","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel, R. et al. ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 35, 2873\u20132926 (2014).","journal-title":"Eur Heart J."},{"key":"31298_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-2796.1997.115125000.x","volume":"241","author":"A Savolainen","year":"1997","unstructured":"Savolainen, A., Kupari, M., Toivonen, L., Kaitila, I. & Viitasalo, M. Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med. 241, 221\u2013226 (1997).","journal-title":"J Intern Med."},{"key":"31298_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0735-1097(02)02699-2","volume":"41","author":"AT Yetman","year":"2003","unstructured":"Yetman, A. T., Bornemeier, R. A. & McCrindle, B. W. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol. 41, 329\u2013332 (2003).","journal-title":"J Am Coll Cardiol."},{"key":"31298_CR11","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.ijcard.2012.06.036","volume":"167","author":"BA Hoffman","year":"2013","unstructured":"Hoffman, B. A. et al. Prospective risk stratification of sudden cardiac death in Marfan\u2019s syndrome. Int J Cardiol. 167, 2539\u20132545 (2013).","journal-title":"Int J Cardiol."},{"key":"31298_CR12","doi-asserted-by":"publisher","first-page":"e81281","DOI":"10.1371\/journal.pone.0081281","volume":"8","author":"A Aydin","year":"2013","unstructured":"Aydin, A. et al. Observational Cohort Study of Ventricular Arrhythmia in Adults with Marfan Syndrome Caused by FBN1 Mutations. PLoS One. 8, e81281 (2013).","journal-title":"PLoS One."},{"key":"31298_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tcm.2017.07.010","volume":"28","author":"RL Woosley","year":"2018","unstructured":"Woosley, R. L., Black, K., Heise, C. W. & Romero, K. CredibleMeds.org: What does it offer? Trends Cardiovasc Med. 28, 94\u201399, https:\/\/www.crediblemeds.org (2018).","journal-title":"Trends Cardiovasc Med."},{"key":"31298_CR14","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori, S. G. et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 36, 2793\u20132867 (2015).","journal-title":"Eur Heart J."},{"issue":"suppl","key":"31298_CR15","first-page":"14","volume":"27","author":"PW Macfarlane","year":"1995","unstructured":"Macfarlane, P. W., McLaughlin, S. C., Devine, B. & Yang, T. F. Effects of age, sex, and race on ECG interval measurements. J Electrocardiol. 27(suppl), 14\u201319 (1995).","journal-title":"J Electrocardiol."},{"key":"31298_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1542-474X.2002.tb00189.x","volume":"7","author":"F Extramiana","year":"2002","unstructured":"Extramiana, F. et al. Cardiac effects of chronic oral beta-blockade: lack of agreement between heart rate and QT interval changes. Ann Noninvasive Electrocardiol. 7, 379\u2013388 (2002).","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"31298_CR17","unstructured":"International conference on harmonization of technical requirements for registration of phqrmaceuticals for human use. The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs \u2013 ICH E14. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Guideline.pdf."},{"key":"31298_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jacc.2013.02.060","volume":"62","author":"CS Sriram","year":"2013","unstructured":"Sriram, C. S. et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 62, 222\u2013230 (2013).","journal-title":"J Am Coll Cardiol."},{"key":"31298_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","volume":"132","author":"C Basso","year":"2015","unstructured":"Basso, C. et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation. 132, 556\u2013566 (2015).","journal-title":"Circulation."},{"key":"31298_CR20","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.hrthm.2009.08.031","volume":"6","author":"ZH Tseng","year":"2009","unstructured":"Tseng, Z. H. et al. Association of TGF\u03b2R2 Polymorphism with Risk of Sudden Cardiac Arrest in Patients with Coronary Artery Disease. Heart Rhythm. 6, 1745\u20131750 (2009).","journal-title":"Heart Rhythm."},{"key":"31298_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvs230","volume":"96","author":"W Chu","year":"2012","unstructured":"Chu, W. et al. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. Cardiovasc Res. 96, 90\u201398 (2012).","journal-title":"Cardiovasc Res."},{"key":"31298_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCEP.114.001837","volume":"8","author":"G Teng","year":"2015","unstructured":"Teng, G. et al. Role of mutation and pharmacologic block of hERG (KCNH2) in vasculogenesis and fetal mortality: partial rescue by TGB\u03b2. Circ Arrhythm Electrophysiol. 8, 420\u2013428 (2015).","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"31298_CR23","doi-asserted-by":"crossref","unstructured":"Napolitano, C., Novelli, V., Francis, M. D. & Priori, S. G. Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact. Curr Opin Genet Dev 33, 17\u201324 (2015).","DOI":"10.1016\/j.gde.2015.06.009"},{"key":"31298_CR24","doi-asserted-by":"publisher","first-page":"e106602","DOI":"10.1371\/journal.pone.0106602","volume":"9","author":"JF Gomez","year":"2015","unstructured":"Gomez, J. F., Cardona, K., Romero, L., Ferrero, J. M. Jr. & Trenor, B. (2014) Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study. PLoS One. 9, e106602 (2015).","journal-title":"PLoS One."},{"key":"31298_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","volume":"119","author":"GM Vincent","year":"2009","unstructured":"Vincent, G. M. et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures\u201d. Circulation. 119, 215\u2013221 (2009).","journal-title":"Circulation."},{"key":"31298_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz, P. J. et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 103, 89\u201395 (2001).","journal-title":"Circulation."},{"key":"31298_CR27","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron, O. et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J. 36, 2160\u20132166 (2015).","journal-title":"Eur Heart J."},{"key":"31298_CR28","doi-asserted-by":"publisher","first-page":"417e26","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","volume":"62","author":"A De Paepe","year":"1996","unstructured":"De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. & Pyeritz, R. E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 62, 417e26 (1996).","journal-title":"Am J Med Genet."},{"key":"31298_CR29","doi-asserted-by":"publisher","first-page":"476e85","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys, B. L. et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 47, 476e85 (2010).","journal-title":"J Med Genet."},{"key":"31298_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","volume":"53","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju, P. M. et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 53, 982\u2013991 (2009).","journal-title":"J Am Coll Cardiol."},{"key":"31298_CR31","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori, S. G. et al. HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 10, 1932\u20131963 (2013).","journal-title":"Heart Rhythm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31298-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:06:26Z","timestamp":1671613586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31298"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31298-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Abifadel reports personal fees from Amgen, personal fees from Sanofi, outside the submitted work; Dr. Boileau reports grants from ANR (National Research Funding Agency), grants from PHRC (French Ministry of Health), outside the submitted work; Dr. Denjoy reports personal fees from GILEAD, outside the submitted work; Dr. Extramiana reports personal fees and non-financial support from Bayer, non-financial support from Biosense Webster, non-financial support from Biotronik, non-financial support from Boston Scientific, personal fees from Da\u00efchi-Sankyo, non-financial support from Medtronic, personal fees from Menarini, personal fees from Pfizer, non-financial support from Saint Jude Medical, personal fees and non-financial support from Sanofi, outside the submitted work; Dr. Leenhardt reports personal fees from Sanofi, personal fees from Meda Pharma, outside the submitted work; Dr. Maison-Blanche reports personal fees from Banook central Lab, personal fees from Chiesi Pharmaceutical, personal fees from Sanofi, personal fees from Novartis, outside the submitted work; Dr Jondeau reports grants from ANR (National Research Funding Agency), grants from PHRC (French Ministry of Health), federation de cardiologie, foundation francaise de cardiologie, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13019"}}